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Production of monocyte chemoattractant protein-i by bovine glomeru-
lar endothelial cells. To explore the role of glomerular endothelial cells
(GEN) in the pathogenesis of glomerulonephritis, the in vitro production
of monocyte chemoattractant protein-I (MCP-1) by bovine GEN was
determined by chemotaxis assay, Northern and Western blot analysis, and
immunocytochemistry. Monocyte chemotactic activity of GEN-condi-
tioned media was detectable by a chemotaxis assay using human periph-
eral blood monocytes. Exposure to human recombinant interleukin-1/3
(IL-1/3) and phorbol myristate acetate (PMA) significantly increased the
chemotactic activity of GEN-conditioned media. A checkerboard analysis
showed that the response of monocytes to GEN-conditioned media was
truly chemotactic. Immunoadsorption with a monoclonal antibody to
human MCP-1 reduced the chemotactic activity of GEN-conditioned
media by 85%. Northern blot analysis revealed that MCP-l mRNA was
constitutively expressed by GEN and that IL-1/3 and tumor necrosis
factor-a (TNF-a) increased MCP-1 mRNA levels in a dose- and time-
dependent manner. Furthermore, PMA induced an increase in MCP-1
mRNA levels, whereas dibutyryl cyclic AMP and forskolin had minimal
effects. Inhibition study using protein kinase inhibitors revealed that
MCP-1 mRNA expression induced by IL-1j3 and TNF-a was suppressed
by the tyrosine kinase inhibitor genistein, not by the protein kinase C
inhibitors staurosporine or H-7, or the protein kinase A inhibitor H-89,
suggesting an important role of tyrosine kinase in the cytokine-induced
MCP-1 gene expression. Dexamethasone had a small inhibitory effect on
constitutive MCP-1 mRNA expression, but no effect on the induction by
TNF-a. By immunoperoxidase staining and Western blot analysis using an
anti-MCP-1 monoclonal antibody, MCP-1 protein was detected in un-
treated GEN and increased by exposure to TNF-a. These results demon-
strate the cytokine-induced production of MCP-1 by GEN at gene and
protein levels as well as bioactivity, and suggest that GEN may participate
in the development of glomerulonephritis through the production of
MCP-1.
There are numerous reports concerned with the role of glomer-
ular intrinsic cells in the pathogenesis of glomerulonephritis [1].
In particular, glomerular mesangial cells have been described to
act as effector cells through their functions including proliferative
response to various stimuli, antigen presentation, and release of a
variety of biologically active substances such as prostaglandins,
cytokines, oxygen radicals, proteinases and extracellular matrix
proteins [2, 3]. Furthermore, studies with glomerular epithelial
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cells have been performed, but to lesser extent, to clarify their
association with the development of glomerular injury [4, 5]. In
contrast, little information of glomerular endothelial cells (GEN)
is available. However, since GEN are exposed directly to circu-
lating factors and closely apposed to glomerular basement mem-
brane and mesangial cells, it is likely that GEN act not only as a
barrier to the movement of molecules out of the glomerular
capillaries, but also influence functions of mesangial cells and
glomerular hemodynamics, and hence play a role in the patho-
genesis of glomerulonephritis. Recently, the in vitro interaction of
GEN with mesangial cells has been demonstrated, in which the
prostaglandin synthesis of mesangial cells can be modulated by
endothelin-1 derived from GEN [6]. Thus, it is feasible that GEN
may participate in the development of glomerular injury.
Since inflammatory infiltrate may contribute to tissue injury
through local production of a number of inflammatory mediators,
mechanisms by which leukocytes are recruited to the inflamed
tissue have been studied focusing on leukocyte adhesion mole-
cules and chemotactic factors [7]. In addition to complement
components, platelet activating factor, and leukotrienes, a chemo-
kine family has been identified as peptides inducing chemotaxis of
neutrophils, monocytes/macrophages and T lymphocytes [81.
Monocyte chemoattractant protein-i (MCP-1), a member of
chemokine 13-subfamily, is a chemotactic and activating peptide
highly specific for monocytes [9]. This peptide is produced by
various cells including vascular endothelial cells [10] and synovio-
cytes [11] in vitro, and is expressed in atherosclerotic lesions [12,
13] and the inflamed synovial tissue [11, 14] in vivo. Glomerular
infiltration of monocytes/macrophages has been emphasized to
cause glomerular injury [15, 16]. It is therefore likely that this
peptide may be an important factor on the pathogenesis of
immune-mediated glomerulonephritis. Indeed, recent reports
have described the in vitro production of MCP-1 by glomerular
mesangial cells [17, 18] and epithelial cells [19], and glomerular
expression of MCP-1 mRNA in anti-thymocyte antibody-induced
glomerulonephritis [20], suggesting the association of this peptide
with glomerular injury.
In the present study, we demonstrated the production of
MCP-1 by GEN at bioactivity, mRNA and protein levels, which is
regulated by inflammatory cytokines, suggesting a novel role of
GEN in the pathogenesis of immune-mediated glomerulonephri-
tis.
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Methods
Materials
All of reagents for cell culture were purchased from GIBCO
(Grand Island, NY, USA), except collagenase and gelatin from
Sigma Chemical Co. (St. Louis, MO, USA) and endothelial cell
growth supplement (ECGS) from Becton Dickinson (Bedford,
MA, USA). A 48-well microchemotaxis chamber and polyvi-
nylpyrrolidone-free polycarbonate filters (pore size 5 jim) were
purchased from Neuroprobe (Cabin John, MD, USA). Rabbit
antiserum to human von Willebrand factor, peroxidase-conju-
gated rabbit anti-mouse immunoglobulin and swine anti-rabbit
immunoglobulin were purchased from Dakopatts (Glostrup, Den-
mark). Diaminobenzidine tetrahydrochloride (DAB), bovine se-
rum albumin (BSA), dextran, EDTA-2Na, phorbol 12-myristate
13-acetate (PMA), dibutyryl cyclic AMP (cAMP), forskolin, stau-
rosporine, H-7 and protein A-sepharose were purchased from
Sigma. H-89 was purchased from BIOMOL Research Laborato-
Ties (Plymouth Meeting, PA, USA) and genistein from Extrasyn-
these (Genay, France). Fluorescent acetylated low density ii-
poprotein (LDL) was purchased from Molecular Probes (Eugene,
OR, USA). Recombinant human interleukin-113 (IL-13) and
tumor necrosis factor-a (TNF-cs) were purchased from Genzyme
(Cambridge, MA, USA). NycoPrep°°1.068 solution was purchased
from Nycomed Pharma (Oslo, Norway). A monocional antibody
(5881) to human MCP-1 was purchased from Pepro Tech (Rocky
Hill, NJ, USA). Chromatographically purified mouse IgG was
purchased from Zymed Laboratories (San Francisco, CA, USA).
Hybond-N nylon membranes, rapid hybridization buffer and
peroxidase-conjugated sheep anti-mouse immunoglobulin were
purchased from Amersham Japan (Tokyo, Japan). Random
primer DNA labeling system was purchased from Takara Bio-
medicals (Kyoto, Japan). Nonidet p-40 was purchased from
Nacalai Tesque Inc. (Kyoto, Japan). Nitroceliulose membrane
was purchased from Bio-Rad Laboratories (Hercules, CA, USA).
Cell culture
Bovine GEN were established by a modification of the method
described previously [21]. Briefly, bovine kidneys were obtained
from a local slaughterhouse and giomeruli were isolated with a
sieving technique [22] using sterile stainless steel sieves with pore
sizes 250, 180, and 100 jim. Glomerular remnants after collage-
nase digestion were sedimented at 500 g for three minutes. Cells
in the supernatant were seeded on 0.2% gelatin-coated tissue
culture plates in RPMI164O medium containing 15% fetal bovine
serum, 50 jig/mI ECGS, 50 U/mi heparin sodium, 5 mrvi HEPES
buffer, and antibiotics. Fourteen days after plating, cell colonies
were isolated with cloning cylinders and passaged using a trypsin-
EDTA solution. The cell colonies were isolated again with cloning
cylinders and passaged to obtain homogeneous cell populations.
Individual clones obtained by the second cloning step were tested
for characteristics of endothelial cells. Cells exhibited a 'cobble-
stone' like morphology at confluent state and showed positive
reaction by indirect immunofluorescence staining using rabbit
antiserum to human von Willebrand factor. When cells were
incubated for 12 hours at 37°C with 30 jig/mI fluorescent acety-
lated LDL, marked endocytosis of the reagent was observed. Cells
between the fifth and eighth passage were used for the experi-
ments.
Time, hours
Fig. 1. Production of monocyte chemotactic activity by bovine GEN. GEN
were maintained in 24-well cluster dishes. Medium was replaced to fresh
RPMI164O medium containing 0.25% BSA (Time 0). Conditioned media
were harvested at various intervals and tested for monocyte chemotactic
activity. The results represent the mean SEM of triplicate values. P <
0.01 versus Time 0.
Preparation of conditioned media
GEN were added at 1 X 103/well in 24-well cluster dishes
precoated with 0.2% gelatin. After five days, confluent cells were
washed three times with RPMI164O medium and incubated in
RPMII64O medium containing 0.25% BSA and factors tested.
Conditioned media were harvested at various intervals, centri-
fuged to remove cell debris, and stored at —20°C until tested.
Collection of human peripheral blood monocytes
Human peripheral blood monocytes were freshly isolated from
healthy volunteers by the method previously described [23], using
NycoPrep°° 1.068 solution. Briefly, EDTA-treated blood was
mixed with 6% dextran (10:1). When erythrocytes had settled,
leukocyte-rich plasma was removed and layered over the Nyco-
Prep solution. After centrifugation at 600 g for 15 minutes, the
clear plasma was removed, and the remainder of the plasma and
the NycoPrep solution were collected. The cell suspension was
diluted and washed three times with 0.9% NaC1 containing 0.15%
EDTA-2Na and 1% BSA. The cells were resuspended in
RPMI164O containing 0.25% BSA. The resulting population
usually contained 75 to 85% monocytes, the rest being lympho-
cytes.
Chemotaxis assay
Chemotactic activity of conditioned media was assessed by the
method previously described [24] using a 48-well chemotaxis
chamber. Briefly, conditioned media (25 pA) were added to the
lower wells of the chamber. Responder cells (human monocytes)
suspended in RPMI164O medium containing 0.25% BSA were
added to the upper wells of the chamber (3 x i0 cells/SO jil/well).
After incubation for 90 minutes at 37°C, the polycarbonate filters
(pore size 5 jim) separating the upper and lower wells of the
chamber were removed, fixed in methanol, and stained with
Duff-Quick. Monocytes that migrated completely through the filter
pores were quantified by counting 10 random high power fields
(x400, HPF). The number of migrating cells per one HPF was
evaluated. Results were expressed as the mean SEM of tripli-
cated values for migrating cells, or net cells that were subtracted
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Fig. 2. Effect of IL-I and PMA on the production of monocyte chemotactic activity by bovine GEN. GEN were exposed to medium alone (•), IL-1f3 (1
ng/ml; U), or PMA (20 ng/ml; ) for 6 or 24 hours (A), and to various concentrations of IL-1$ or PMA for six hours (B). Conditioned media were
harvested and assessed for monocyte chemotactic activity. The results represent the mean SCM of triplicate values. Random migration was 2.7 0.3
and 4.5 0.6 cells/HPF in (A) and (B). < 0.05, °°P < 0.01 versus medium alone.
Table 1. Modified checkerboard analysis of the chemotactic response
of monocytes to GEN-conditioned media
Lower
wells
Upper wells
oa 8 25 75
oa o 0 0 0
8 2.4 0.4
25 5.4 0.3
75 6.3 3.3 0.8 0
a Percentage of GEN-conditioned media applied to the lower and upper
wells of the chemotaxis chamber
'Number of net migrated monocytes (cells/HPF) subtracted by mono-
cytes migrating randomly. The results represent the mean of triplicate
values.
by cells migrating randomly. Random migration was defined as
the response to RPMI164O medium containing 0.25% BSA alone.
Irnrnunoadsorption study
To determine whether monocyte chemotactic activity of condi-
tioned media is caused by MCP-1 derived from GEN, we at-
tempted to neutralize chemotactic activity by immunoadsorption
with a monoclonal antibody to human MCP-1. Conditioned media
were incubated for one hour at 37°C with 150 jxg/ml of anti-
MCP-1 antibody (5881), nonimmune mouse IgO, or medium
alone, followed by the addition of 2 mg of protein A-sepharose 4B
for one hour. The mixture was then centrifuged to remove the
protein-A sepharose binding MCP-1/anti-MCP-1 antibody com-
plexes, and the remaining chemotactic activity in the supernatant
was measured.
Northern blot analysis
GEN were maintained in 100-mm tissue culture dishes and
stimulated at confluency with factors as indicated. Total RNA was
extracted by a single step guanidinium thiocyanate-phenol-chlo-
roform method [25]. Aliquots of 20 jig of total RNA were
separated on 1% formaldehyde gels, and transferred to Hybond-N
nylon membranes. The cDNA probe for human MCP-1 [26] was
labeled with [cv-32PJdCTP by a random primer DNA labeling
system. The blots were prehybridized in a rapid hybridization
buffer for at least three hours at 65°C, hybridized with the
32P-labeled cDNA probe for two hours at 65°C, and washed in 2
X SSC, 0.1% SDS at room temperature (2 X 15 mm) and 1 x
SSC, 0.1% SDS at 55°C (2 X 15 mm). The membranes were
exposed to Kodak ARO film at —70°C for three days. To confirm
equal RNA load and complete transfer the 18S and 28S bands
were visualized with ethidium bromide on all membranes.
Immunoperoxidase staining of GEN
GEN were stained with a monoclonal antibody to MCP-1 by a
peroxidase staining reaction as described previously [271. Cells
were stimulated for six hours with factors tested, and then fixed
for 15 minutes at 4°C with the periodate-lysine-paraformaldehyde
reagent. After washing, the cells were incubated with mouse
anti-human MCP-1 antibody (F9) [281, peroxidase-conjugated
rabbit anti-mouse immunoglobulin, and peroxidase-conjugated
swine anti-rabbit immunoglobulin, and were then treated with
DAB, counterstained, and observed.
Western blot analysis
GEN were maintained in 60-mm tissue culture dishes and
stimulated at confluency with factors as indicated. After being
washed with PBS, the cell layer was incubated on ice for 30
minutes into 1 ml of lysis buffer containing 1% Nonidet P-40, 150
mM NaC1, 1 mri PMSF, and 50 mist Tris, pH 8.0, with occasional
rocking. The cell lysate was removed and centrifuged for 10
minutes at 10,000 g at 4°C. The supernatants obtained were
corrected for total amount of protein and subjected to electro-
phoresis on 15% polyacrylamide gels under reducing conditions as
described previously [29]. The proteins were electrophoretically
transferred to nitrocellulose membranes. The membranes were
blocked with 5% powdered milk/PBS overnight at 4°C. Individual
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Fig. 3. Immunoadsorption of GEN-derived
chemotactic activity by a specific mouse anti-
MCP-l antibody. Conditioned media from PMA
(10 ng/ml)-treated GEN were adsorbed with
150 jsglml anti-MCP-1 monoclonal antibody.
The remaining chemotactic activity was
measured and compared with that of the
conditioned media incubated without antibody
or with nonimmune mouse IgG. The results
represent the mean SEM of triplicate values.Mouse Random migration was 4.5 0.6 and 3.5 1.2
IgG cells/HPF in experiments 1 and 2, respectively.
< 0.01 versus Ab(—).
A
TNF-ct IL-1
(ng/mI) 0 1 10 100 0 1 10
MCP-1
1 8S
B
TNF-ct
0 1 2 4 8 24 (hours)
Fig. 4. Effect of TNF-a and IL-i on the expression of MCP-i mRNA in bovine GEN. Bovine GEN were stimulated for six hours with various
concentrations of TNF-a and IL-i/I in (A), and for various intervals with TNF-cr (10 ng/ml) in (B). Total RNA was extracted and analyzed by Northern
blotting.
strips were then reacted overnight with 20 xg/ml mouse anti-
human MCP-1 antibody (F9) and reacted for four hours at room
temperature with peroxidase-conjugated sheep anti-mouse immu-
noglobulin F(ab')2 fragment (at a dilution of 1:300) in 5%
powdered milk/PBS. After being washed, the strips were devel-
oped with DAB. The reaction was stopped by washing with
distilled water.
Statistical analysis
Statistical differences between groups were evaluated by using
unpaired Student's t-test. P values <0.05 were considered signif-
icant.
Results
Monocyte chemotactic activity of GEN-conditioned media
When GEN-conditioned media were added to the lower wells
of the chemotaxis chamber, number of migrated monocytes was
significantly increased, compared with the response to control
medium. This chemotactic activity was detectable as early as six
hours after adding fresh medium and was augmented by 18 hours
(Fig. 1). A six-hour exposure of GEN to IL-1)3 and PMA
enhanced monocyte chemotactic activity of conditioned media
(278% and 372% increase by IL-1/3 and PMA). Similar, but to
lesser extent, enhancement of chemotactic activity was induced by
a 24-hour exposure to those (41% and 171% increase by IL-i/I
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Fig. 6. Effect of protein kinase inhibitors on the expression of MC?-] mRNA in bovine GEN. Bovine GEN were preincubated for 60 minutes with
staurosporine (100 nM), H-7 (10 jIM), genistein (20 jg/ml), or H-89 (1 jM). The cells were then stimulated for four hours with TNF-cs (10 nglml) in
(A), and with PMA (10 ng/ml) in (B). Total RNA was extracted and analyzed by Northern blotting. Comparable results were obtained in three sets of
experiments.
and PMA), as shown in Figure 2A. When GEN were exposed to
various doses of the factors, significant response was induced by as
little as 0.1 ng!ml of IL-l3 (Fig. 2B).
Modified checkerboard analysis
A modified checkerboard analysis was performed to evaluate
the nature of monocyte migration induced by GEN-conditioned
media, in which m000cytes were exposed to different gradient
conditions of conditioned media (Table 1). When the concentra-
tions of conditioned media were higher in the lower wells,
increases in migrated monocytes were observed in a concentra-
tion-dependent fashion. Reduction of the concentration gradient
by adding conditioned media to the upper wells inhibited mono-
cyte migration. In contrast, when the concentrations were identi-
cal or higher in the upper wells, little or no migration was induced.
The results indicate that GEN-conditioned media induced a pure
chemotactic, not chemokinetic, response of monocytes.
Immunoadsorption of monocyte chemotactic activity with a
specific anti-MCP-1 monoclonal antibody
To examine that the chemotactic activity of GEN-conditioned
media is mediated by MCP-1, we attempted to neutralize the
chemotactic activity with a specific anti-MCP-1 antibody. Treat-
ment with anti-MCP-1 antibody markedly reduced the chemotac-
tic activity of conditioned media (85 and 66% decrease in two
separate experiments). On the other hand, treatment with non-
immune mouse IgG had no effect on the ehemotactic activity (Fig.
3).
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Fig. 5. Effect of PMA, cAMP, and forskolin on
the expression of MCP-1 mRNA in bovine GEN.
Bovine GEN were stimulated for six hours with
PMA (10 ng/ml), cAMP (1 mM), or forskolin
(100 jLM) in (A) for various intervals with PMA
(10 nglml) in (B). Total RNA was extracted
and analyzed by Northern blotting.
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Fig. 7. Effect of dexamethasone on TNF-a-induced expression of MCP-1
mRNA in bovine GEN. Bovine GEN were stimulated for six hours with
TNF-a (10 nglml) in the presence or absence of dexamethasone (DEX) (1
Total RNA was extracted and analyzed by Northern blotting.
Comparable results were obtained in three sets of experiments.
MCP-1 mRNA expression in GEN
There was a detectable basal level of MCP-1 message that was
increased by exposure to IL-l/3 and TNF-a in a dose dependent-
manner (Fig. 4A). Induction of MCP-1 mRNA expression by
TNF-a was observed at one hour and reached a maximum at 24
hours (Fig. 4B). Similar pattern of the time-dependent expression
of MCP-1 mRNA was observed in cells stimulated with IL-1/3
(data not shown). To investigate the involvement of protein
kinases, GEN were exposed to protein kinase activators as PMA,
cAMP and forskolin. In contrast to cAMP and forskolin that had
minimal effects, PMA enhanced the expression of MCP-1 mRNA
with a maximum at four hours, and subsequently the levels of
MCP-1 mRNA were decreased, probably by the down regulation
of protein kinase C (Fig. 5 A, B). Inhibition study using protein
kinase inhibitors revealed that TNF-a-induced expression of
MCP-1 mRNA was abrogated by the tyrosine kinase inhibitor
genistein, not by the protein kinase C inhibitors staurosporine or
H-7, or the protein kinase A inhibitor H-89, suggesting that the
activation of tyrosine kinase, not of protein kinase A or C, may be
associated with the cytokine-induced expression of MCP-1 gene
(Fig. 6A). Similar inhibitory effect of genistein was observed in
IL-i /3-stimulated cells (data not shown). PMA-induced expression
of MCP-1 mRNA was suppressed only by staurosporine and H-7
(Fig. 6B). Furthermore, dexamethasone had no effect on TNF-a-
induced expression of MCP-l mRNA, although its inhibitory
effect on MCP-1 gene expression in other cells has been previ-
ously described (Fig. 7) [30, 31].
Detection of MCP-1 protein by immunocytochemistiy and Western
blot analysis
To determine the production of MCP-l protein, a monolayer of
GEN was stained with a immunoperoxidase labeling technique
using a monoclonal antibody to human MCP-1. As shown in
Figure 8, MCP-l protein was faintly detected in untreated GEN
and exposure to TNF-a increased the expression of MCP-l
protein. In contrast to TNF-a, dexamethasone did not appear to
affect the MCP-1 protein production. Furthermore, the detergent
lysates of GEN were subjected to SDS-PAGE and transferred to
nitrocellulose membranes for Western blotting with anti-MCP-1
monoclonal antibody. Figure 9 represents two bands of 30- and
60-kDa detected. The intensity of both bands seemed to be
increased in the cell lysates of GEN stimulated with TNF-a and
PMA, compared to untreated GEN. The results indicate the
cytokine-induced MCP-1 production by GEN at protein level as
well as bioactivity and gene expression.
Discussion
We demonstrated that GEN produce monocyte chemotactic
activity, which is increased by exposure to inflammatory cytokines
as lL-l/3. A checkerboard analysis revealed that GEN-condi-
tioned medium is truly chemotactic for monocytes. Immunoad-
sorption study with a specific antibody to MCP- 1 suggests that the
chemotactic activity of GEN-conditioned medium is mainly me-
diated by MCP-1. However, the failure of complete elimination of
the chemotactic activity by immunoadsorption could not exclude
the possible production of other chemotactic factors including
transforming growth factor-/3 (TGF-13) and macrophage inflam-
matory protein-la that can act as a monocyte chemoattractant
[32, 33], although the problem of the species specificity of the
antibody still remains. Northern analysis revealed the expression
of MCP-1 gene by GEN. Stimulation of GEN with inflammatory
cytokines such as IL-I /3 and TNF-a caused an increase in MCP-i
mRNA levels, corresponding to an increase in monocyte chemo-
tactic activity.
In addition, immunoperoxidase staining and Western blot
analysis using an anti-MCP-1 monoclonal antibody demonstrated
the production of MCP-l by GEN at protein level as well as
bioactivity and gene expression. However, the enhancement of
MCP-l protein production detected by immunocytochemistry and
Western blotting appeared to be less than that detected by a
chemotaxis assay and Northern analysis. This may reflect the
species specificity and sensitivity of the antibody used, By Western
blot analysis, the 30- and 60-kDa bands were detected in both
untreated and stimulated GEN. Previous study to determine the
size of native MCP-l produced by mouse fibroblasts and macro-
phages demonstrated that the predominant species of MCP-l
produced is the highly glycosylated 30-kDa glycoprotein and that
the smaller MCP-1 forms were not detected by Western blotting
[34], being consistent with the present study. Furthermore, study
using a combination of size exclusion chromatography, sedimen-
tation equilibrium ultracentrifugation, and chemical cross-linking
demonstrated that the association states of MCP-l are character-
ized by an equilibrium between monomers and dimers: MCP-1 is
dimeric at concentrations above 100 sM and monomeric at the
nanomolar concentrations [35]. This suggests that the 60-kDa
band detected in the present study may be a dimer of the highly
glycosylated form of MCP-1.
Glomerular macrophage infiltration has been observed in a
variety of human glomerular diseases, and it has recently been
suggested that macrophages may play an important role in the
development of glomerulosclerosis as well as mediation of acute
glomerular injury, through secretion of a number of biologically
active products [15]. Since MCP-1 is thought to be a major
monocyte chemotactic factor, studies have been performed to
prcy' A_
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Fig. 8. Detection of MCP-l protein by
immunocytochemistiy in bovine GEN. Bovine
GEN were stimulated for six hours with factors
tested, and analyzed by immunoperoxidase
staining using the anti-MCP-1 monoclonal
antibody (F9). (A) Mouse IgG was used as the
primary antibody (negative control). (B)
Untreated GEN. (C) TNF-a (10 ng/ml)-treated
GEN. (D) Dexamethasone (1 jLM)-treated
GEN. Comparable results were obtained in
three sets of experiments.
clarify the role of MCP-1 in the development of glomerular injury.
The in vitro studies have demonstrated that human mesangial cells
produce MCP-1, which is enhanced by IL-i and TNF-a [17], and
that the expression of MCP-1 mRNA in mouse mesangial cells
was regulated by TNF-a, IFN-y, IgG aggregates and cAMP [18,
36]. Recent work has also shown the MCP-1 production by
glomerular epithelial cells in culture [19]. In addition to these
findings, the present study suggests that GEN may be important as
an additional source of intraglomerular MCP-1 production. In
deed, the in vivo expression of MCP-1 associated with the
accumulation of monocytes/macrophages in glomeruli were ob-
served at transcription and protein levels in rat anti-thymocyte
antibody-induced glomerulonephritis [20], in which GEN as well
as mesangial cells seemed to be a source of MCP-1, being
consistent with the present study. Furthermore, in human renal
diseases, glomerular expression of MCP-1 has been demonstrated
in patients with lupus nephritis, Wegener's granulomatosis, and
crescentic glomerulonephritis [37].
Because MCP-1 may play an important role in the migration
and activation of monocytes in glomerulonephritis as mentioned
above, mechanisms by which the production of MCP-i can be
regulated are of interest. Studies have been performed to inves-
tigate regulation of MCP-1 production by inflammatory cytokines
and growth factors, and intracellular signaling pathways directly
used in the induction of MCP-1 gene. In human articular chon-
drocytes and synoviocytes, steady state levels of MCP-1 mRNA
were increased by IL-i, TNF-a, PDGF, TGF-f3, PMA, and cAMP
[11, 30]. In mouse mesangial cells, up-regulation of MCP-1
mRNA expression by TNF-a and IFN-y was attenuated by
stimulation of cAMP generation, and changes in MCP-1 mRNA
expression paralleled those in activation of NF-KB [38], which is
an important transcription factor as a pleiotropic regulator of
endothelial activation [39]. Furthermore, induction of MCP-1
gene expression by IL-i in human mesangial cells may be medi-
ated by the activation of protein tyrosine kinase, not protein
kinase A or C, phosphorylation of which activates NF-KB or AP-1
[40]. In the case of GEN, as shown in the present study, the
expression of MCP-1 mRNA was induced by IL-lp and TNF-a.
PMA also induced MCP-1 mRNA expression, but cAMP and
forskolin had no effect. Inhibition study with pharmacologic
inhibitors of protein kinases demonstrated that effects of these
cytokines may be mediated through the activation of tyrosine
kinase, not protein kinase A or C. Thus, the results suggest an
important role of tyrosine kinase in the cytokine-induced expres-
sion of MCP-1 gene by GEN.
Recently, an important role of GEN in the development of
glomerulonephritis has been suggested. Cultured GEN release
nitric oxide [41] and endothelin-1 [42] which can affect functions
of mesangial cells such as contraction, proliferation, and prostag-
landin synthesis, and hence influence glomerular hemodynamic
function. Furthermore, since various cytokines modulate mesang-
ial functions such as proliferation and production of cytokines and
extracellular matrix [2, 22, 27, 43, 44], the ability of GEN to
produce cytokines and growth factors such as interleukin-6 [45]
Medium PMAalone12 12
Fig. 9. Detection of MCP-1 protein by Western blot analysis in bovine GEN.
Bovine GEN were stimulated for 24 hours with PMA (10 ng/ml) or TNF-a
(10 nglml). The cell lysates were analyzed by Western blotting using the
anti-MCP-1 monoclonal antibody (F9). Lane 1: Anti-MCP-1 antibody.
Lane 2: Nonimmune mouse IgG as negative control. Comparable results
were obtained in two sets of experiments.
and platelet-derived growth factor [46] may be important in the
regulation of mesangial cell activation. In addition to these
findings, GEN production of MCP-1 as shown in the present study
may be associated with the recruitment of inflammatory infiltrate
into glomeruli, as well as cytokine-induced expression of leuko-
cyte adhesion molecules by GEN [47].
In conclusion, cultured GEN are stimulated to produce MCP-1
by inflammatory cytokines as IL-1/3 and TNF-a. Since MCP-1 is a
monocyte chemoattractant and capable of activating monocytes to
induce the production of inflammatory mediators, the production
of MCP-1 may be a novel and important function of GEN in the
context of the pathogenesis of glomerulonephritis.
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